228 related articles for article (PubMed ID: 25489104)
1. Dual-specificity phosphatase 5 regulates nuclear ERK activity and suppresses skin cancer by inhibiting mutant Harvey-Ras (HRasQ61L)-driven SerpinB2 expression.
Rushworth LK; Kidger AM; Delavaine L; Stewart G; van Schelven S; Davidson J; Bryant CJ; Caddye E; East P; Caunt CJ; Keyse SM
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18267-72. PubMed ID: 25489104
[TBL] [Abstract][Full Text] [Related]
2. Dual-specificity phosphatase 5 acts as an anti-inflammatory regulator by inhibiting the ERK and NF-κB signaling pathways.
Seo H; Cho YC; Ju A; Lee S; Park BC; Park SG; Kim JH; Kim K; Cho S
Sci Rep; 2017 Dec; 7(1):17348. PubMed ID: 29229953
[TBL] [Abstract][Full Text] [Related]
3. Visualizing and Quantitating the Spatiotemporal Regulation of Ras/ERK Signaling by Dual-Specificity Mitogen-Activated Protein Phosphatases (MKPs).
Caunt CJ; Kidger AM; Keyse SM
Methods Mol Biol; 2016; 1447():197-215. PubMed ID: 27514808
[TBL] [Abstract][Full Text] [Related]
4. Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.
Ferguson BS; Harrison BC; Jeong MY; Reid BG; Wempe MF; Wagner FF; Holson EB; McKinsey TA
Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9806-11. PubMed ID: 23720316
[TBL] [Abstract][Full Text] [Related]
5. Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5.
Mandl M; Slack DN; Keyse SM
Mol Cell Biol; 2005 Mar; 25(5):1830-45. PubMed ID: 15713638
[TBL] [Abstract][Full Text] [Related]
6. DUSP5 functions as a feedback regulator of TNFα-induced ERK1/2 dephosphorylation and inflammatory gene expression in adipocytes.
Habibian JS; Jefic M; Bagchi RA; Lane RH; McKnight RA; McKinsey TA; Morrison RF; Ferguson BS
Sci Rep; 2017 Oct; 7(1):12879. PubMed ID: 29018280
[TBL] [Abstract][Full Text] [Related]
7. Transformation by Hras(G12V) is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition.
Chen X; Makarewicz JM; Knauf JA; Johnson LK; Fagin JA
Oncogene; 2014 Nov; 33(47):5442-9. PubMed ID: 24240680
[TBL] [Abstract][Full Text] [Related]
8. Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling.
Kidger AM; Rushworth LK; Stellzig J; Davidson J; Bryant CJ; Bayley C; Caddye E; Rogers T; Keyse SM; Caunt CJ
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E317-E326. PubMed ID: 28053233
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the inducible nuclear dual-specificity phosphatase DUSP5 by ERK MAPK.
Kucharska A; Rushworth LK; Staples C; Morrice NA; Keyse SM
Cell Signal; 2009 Dec; 21(12):1794-805. PubMed ID: 19666109
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis.
Chaudhary SC; Alam MS; Siddiqui MS; Athar M
Life Sci; 2009 Jul; 85(5-6):196-205. PubMed ID: 19470390
[TBL] [Abstract][Full Text] [Related]
11. The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs).
Kidger AM; Keyse SM
Semin Cell Dev Biol; 2016 Feb; 50():125-32. PubMed ID: 26791049
[TBL] [Abstract][Full Text] [Related]
12. Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors.
Chiou YS; Sang S; Cheng KH; Ho CT; Wang YJ; Pan MH
Carcinogenesis; 2013 Jun; 34(6):1315-22. PubMed ID: 23385063
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of dual-specificity phosphatase 5 in gastric cancer by promoter CpG island hypermethylation and its potential role in carcinogenesis.
Shin SH; Park SY; Kang GH
Am J Pathol; 2013 Apr; 182(4):1275-85. PubMed ID: 23402999
[TBL] [Abstract][Full Text] [Related]
14. Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion.
Cheepala SB; Yin W; Syed Z; Gill JN; McMillian A; Kleiner HE; Lynch M; Loganantharaj R; Trutschl M; Cvek U; Clifford JL
Mol Cancer; 2009 May; 8():27. PubMed ID: 19432991
[TBL] [Abstract][Full Text] [Related]
15. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model.
Zhao Y; Xue Y; Oberley TD; Kiningham KK; Lin SM; Yen HC; Majima H; Hines J; St Clair D
Cancer Res; 2001 Aug; 61(16):6082-8. PubMed ID: 11507057
[TBL] [Abstract][Full Text] [Related]
17. Distinct intra-mitochondrial localizations of pro-survival kinases and regulation of their functions by DUSP5 and PHLPP-1.
Ohwada W; Tanno M; Yano T; Ong SB; Abe K; Sato T; Kuno A; Miki T; Sugawara H; Igaki Y; Miura T
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165851. PubMed ID: 32480039
[TBL] [Abstract][Full Text] [Related]
18. DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
Buffet C; Hecale-Perlemoine K; Bricaire L; Dumont F; Baudry C; Tissier F; Bertherat J; Cochand-Priollet B; Raffin-Sanson ML; Cormier F; Groussin L
PLoS One; 2017; 12(9):e0184861. PubMed ID: 28910386
[TBL] [Abstract][Full Text] [Related]
19. VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells.
Bellou S; Hink MA; Bagli E; Panopoulou E; Bastiaens PI; Murphy C; Fotsis T
Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1477-89. PubMed ID: 19741200
[TBL] [Abstract][Full Text] [Related]
20. Dual specificity phosphatase 5 regulates perfusion recovery in experimental peripheral artery disease.
Alleboina S; Ayalew D; Peravali R; Chen L; Wong T; Dokun AO
Vasc Med; 2019 Oct; 24(5):395-404. PubMed ID: 31451089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
